POINT Biopharma Global Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
POINT Biopharma Global Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2023.
  • POINT Biopharma Global Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $5.51M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.